Hantz Financial Services, Inc. Jazz Pharmaceuticals PLC Transaction History
Hantz Financial Services, Inc.
- $6.19 Billion
- Q2 2025
A detailed history of Hantz Financial Services, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 360 shares of JAZZ stock, worth $49,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
360
Previous 63
471.43%
Holding current value
$49,600
Previous $8,000
375.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding JAZZ
# of Institutions
562Shares Held
62.7MCall Options Held
563KPut Options Held
77.8K-
Black Rock Inc. New York, NY6.15MShares$847 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$839 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.55MShares$352 Million0.65% of portfolio
-
Capital World Investors Los Angeles, CA2.54MShares$351 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$350 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.64B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...